SCHEMBL7955324

SCHEMBL7955324

C[C@@H]1O[C@H](Oc2ccc([N+](=O)[O-])cc2)[C@@H](OCc2ccccc2)[C@@H]2OC(C)(C)O[C@@H]21

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.43
HTT P42858 1/20 0.37
MAPT P10636 2/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
CYP19A1 P11511 1/20 0.33
CTSV O60911 1/20 0.33
CTSL P07711 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957505 0.87 NT5E (0.47) NT5EHTTMAPTLMNAALDH1A1
SCHEMBL7959152 0.87 NT5E (0.55) NT5EHTTALDH1A1
SCHEMBL7957838 0.87 NT5E (0.47) NT5EHTTMAPTALDH1A1NPC1
SCHEMBL7948147 0.83 ALDH1A1 (0.38) HTTMAPTLMNAALDH1A1NPC1
SCHEMBL7955551 0.83 NT5E (0.45) NT5EHTTMAPTALDH1A1NPC1
SCHEMBL7957730 0.82 NT5E (0.47) NT5EHTTMAPTLMNAALDH1A1
SCHEMBL7958119 0.81 NT5E (0.54) NT5EALDH1A1
SCHEMBL7957443 0.81 NT5E (0.42) NT5EHTTMAPTALDH1A1NPC1
SCHEMBL7149762 0.79 SSTR1 (0.42) MAPTMEN1KMT2ACYP2C19
SCHEMBL1491856 0.78 TACR1 (0.35) NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271342-B1 SERUM STABILITY; FOR TUMOR THERAPY BAYER AKTIENGESELLSCHAFT (DE) 2001-08-07 US disclosed
EP-0819135-B1 SUGAR-MODIFIED CYTOSTATICS BAYER AG (DE) 1999-11-17 EP disclosed
CN-1185786-A Sugar-modified cytostatics BAYER AG (DE) 1998-06-24 CN disclosed